Literature DB >> 23981674

Cross-talk between integrin receptor and insulin-like growth factor receptor in regulation of collagen biosynthesis in cultured fibroblasts.

I Prokop, J Konończuk, A Surażyński, J Pałka.   

Abstract

PURPOSE: Cellular processes are regulated by signals generated by adhesion receptors and growth factor receptors. IGFbinding protein 1 (IGFBP-1) is a molecule which may affect the both signaling pathways through inactivation of IGF-I (ligand for IGF-IR) and binding to RGD region of integrin receptors. Whether this phenomenon is important in communication between insulin-like growth factor receptor (IGF-IR) and β1-integrin receptor in regulation of prolidase activity and collagen biosynthesis is the aim of this study. MATERIAL AND
METHOD: We studied the effects of IGFBP-1, IGF-I, thrombin (integrin activator), echistatin (disintegrin), phosphatidylinositol 3-kinase inhibitor (LY-294002) and ERK 1/2 inhibitors (PD98059 and UO126) on prolidase activity, collagen biosynthesis and expression of proteins participating in pathways generated by these receptors.
RESULTS: Stimulation of β1-integrin and IGF-I receptors by standard ligands was proved to up-regulate collagen synthesis in cultured fibroblasts. IGFBP-1, similarly as echistatin and studied inhibitors, contributed to down-regulation of ERK1/2, Akt, mTOR expression and up-regulation of NFκB. It was accompanied by parallel decrease in prolidase activity and collagen biosynthesis.
CONCLUSION: The data suggest that "cross talk" between IGF-I receptor and integrin receptor may play important role in regulation of prolidase activity and collagen biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23981674     DOI: 10.2478/v10039-012-0072-0

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  8 in total

1.  Airway smooth muscle cells are insensitive to the anti-proliferative effects of corticosteroids: The novel role of insulin growth factor binding Protein-1 in asthma.

Authors:  Hong Bui; Yassine Amrani; Brian Deeney; Reynold A Panettieri; Omar Tliba
Journal:  Immunobiology       Date:  2019-05-23       Impact factor: 3.144

2.  Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy.

Authors:  Jingsheng Yuan; Zhijie Yin; Kaixiong Tao; Guobing Wang; Jinbo Gao
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

3.  miR-19-3p Promotes Autophagy and Apoptosis in Pelvic Organ Prolapse Through the AKT/mTOR/p70S6K Pathway: Function of miR-19-3p on Vaginal Fibroblasts by Targeting IGF-1.

Authors:  Yitong Yin; Meiying Qin; Meng Luan; Zhijun Xia
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-09-01       Impact factor: 2.091

Review 4.  Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging.

Authors:  Meenakshi Gaur; Marek Dobke; Victoria V Lunyak
Journal:  Int J Mol Sci       Date:  2017-01-20       Impact factor: 5.923

5.  Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes.

Authors:  Bibiane Steinecker-Frohnwieser; Heike Kaltenegger; Lukas Weigl; Anda Mann; Werner Kullich; Andreas Leithner; Birgit Lohberger
Journal:  Biochem Biophys Rep       Date:  2017-07-01

6.  Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells.

Authors:  Robert Czarnomysy; Arkadiusz Surażyński; Bożena Popławska; Edyta Rysiak; Natalia Pawłowska; Anna Czajkowska; Krzysztof Bielawski; Anna Bielawska
Journal:  Mol Cell Biochem       Date:  2016-12-19       Impact factor: 3.396

Review 7.  Current Understanding of the Emerging Role of Prolidase in Cellular Metabolism.

Authors:  Magdalena Misiura; Wojciech Miltyk
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

Review 8.  The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.

Authors:  George N Tzanakakis; Eirini-Maria Giatagana; Aikaterini Berdiaki; Ioanna Spyridaki; Kyoko Hida; Monica Neagu; Aristidis M Tsatsakis; Dragana Nikitovic
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.